Arm Holdings Has a $4.9 Billion Business Model on Trial. Here’s What It Means for ARM Stock.
Arm Holdings' revenue grew 22% YoY to $1.29B in Q1 2027, with royalty revenue up 22% and licensing revenue up 23%. The company is expanding beyond smartphones into AI and data centers. A trial with Qualcomm over royalty rates could impact Arm's pricing model and growth. Analysts maintain a 'Moderate Buy' rating, with an average target price of $292.72.
How this was made
The 30-second read
Why it matters
The earnings beat underscores growth, but the Qualcomm lawsuit introduces uncertainty for future royalty pricing.
Market read
ARM’s earnings and trial risk provide a mixed catalyst for traders, balancing strong growth with legal uncertainty.
What to watch
Potential settlement terms with Qualcomm and the pace of AI‑chip adoption may mitigate royalty‑rate pressure.
Background
Arm is transitioning from a smartphone‑centric royalty model to broader AI, data‑center, automotive, and edge workloads.
Ticker impact
Arm reported Q1 fiscal 2027 revenue of $1.29 billion, up 22% YoY, and adjusted EPS of $0.45.
potential downside pressure as investors weigh the trial risk against earnings strength
Robust revenue and EPS beat expectations, yet the ongoing Qualcomm lawsuit could constrain royalty pricing and weigh on the stock.
Market effects
Highlights growing importance of ARM's data‑center and AI royalty streams for the semiconductor sector.
UK‑listed ARM’s results may influence European tech indices.
ARM’s royalty model is a bellwether for semiconductor licensing worldwide.
Counterpoint
Despite the trial, ARM’s diversified AI and data‑center exposure could sustain higher multiples.
Key entities
- companyArm Holdings
UK‑based semiconductor IP licensor listed on NASDAQ as ARM.
- companyQualcomm
Major ARM customer involved in a royalty‑payment lawsuit.
